Murine Responses to Recombinant MVA Versus ALVAC Vaccines Against Tumor-associated Antigens, gp100 and 5T4

Murine Responses to Recombinant MVA Versus ALVAC Vaccines Against Tumor-associated Antigens, gp100 and 5T4

DG Hanwell, B McNeil, L Visan… - Journal of …, 2013 - journals.lww.com

Virally vectored cancer vaccines comprise a new form of
immunotherapy that aim to generate anti-tumo.

Peptide synthesis, peptide modification and peptide library synthesis, please contact:

Eva He

eva@pepmic.com

Pepmic Co., Ltd

www.pepmic.com